Please do not adjust margins
Page 5 of 6
RSC Advances
ARTICLE
Journal Name
adjusted, hence providing a larger design space for developing 3.86–3.31 (m, 8H); 13C NMR (101 MHz, CDClV3i)ewδArti1cl6e8O.n3lin8e,
DOI: 10.1039/C5RA20838F
chemical reactions or systems.
133.08, 130.82, 127.83, 123.25, 65.81.
1
N-(3-Methybenzoyl)morpholine (3ga).32 Light yellow oil. H
NMR (400 MHz, CDCl3) δ 7.23–7.18 (m, 1H), 7.14 (dt, J = 10.8,
5.5 Hz, 2H), 7.09 (d, J = 7.4 Hz, 1H), 3.87–3.19 (m, 8H), 2.28 (d,
J = 8.6 Hz, 3H); 13C NMR (101 MHz, CDCl3) δ 169.59, 137.47,
134.28, 129.54, 127.34, 126.67, 122.95, 65.87, 47.15, 41.44,
20.34.
Experimental
General details
Reaction solvents were obtained commercially, and used
without further purification. Commercial reagents were used
as received. Reaction were monitored by thin-layer
chromatography (TLC) on 0.25mm precoated Merck Silica Gel
60 F254, visualizing with ultraviolet light. 1H/13C NMR spectra
were recorded on 400’54 ascend purchased from Bruker
Biospin AG, operating at 400/100 MHz, respectively. Chemical
shifts (δ) are reported in parts per million (ppm) downfield
from tetramethylsilane (TMS), which was used as internal
standard. Flash column chromatography was performed on
Merck Silica Gel 60 (200-300mesh) using petroleum ether and
ethyl acetate.
1
N-(2-Methybenzoyl)morpholine (3ha).32 Light yellow oil. H
NMR (400 MHz, CDCl3) δ 7.23–7.17 (m, 1H), 7.17–7.10 (m, 2H),
7.08 (d, J = 7.2 Hz, 1H), 3.79–3.65 (m, 4H), 3.49 (s, 2H), 3.16 (d,
J = 4.5 Hz, 2H), 2.24 (s, 3H); 13C NMR (101 MHz, CDCl3) δ
169.07, 134.61, 133.15, 129.48, 128.03, 124.98, 124.80, 65.94,
46.23, 40.88, 25.88, 17.99.
N-(3-Chlorobenzoyl)morpholine (3ia).30 Colourless oil. 1H
NMR (400 MHz, CDCl3) δ 7.35–7.24 (m, 3H), 7.23–7.17 (m, 1H),
3.83–3.23 (m, 8H); 13C NMR (101 MHz, CDCl3) δ 167.77,
136.02, 133.64, 129.00, 128.97, 126.26, 124.14, 65.77, 46.99,
41.45, 25.88.
1
N-(2-Chlorobenzoyl)morpholine (3ja).30 Light yellow solid. H
General procedure for synthesis of compound 3: 0.02mol of
benzyl alcohol 1 was dissolved in 30mL dioxane, which was in
syringe A. And H2O2 (30wt% in water, 0.04mol, 2eq), NaBr (2
mol%) and H2SO4 (1 mol%) were dissolved in 30mL dioxane,
NMR (400 MHz, CDCl3) δ 7.43–7.38 (m, 1H), 7.37–7.27 (m, 3H),
3.89 (ddd, J = 16.6, 11.3, 5.6 Hz, 1H), 3.83–3.73 (m, 3H), 3.73–
3.65 (m, 1H), 3.63–3.55 (m, 1H), 3.34–3.16 (m, 2H); 13C NMR
which was in syringe B. Secondary amine 2 (0.02mol, 2eq) and (101 MHz, CDCl3) δ 165.95, 134.37, 129.35, 129.32, 128.68,
126.83, 126.28, 65.80, 65.71, 46.10, 41.05.
TBHP (70wt% in water, 0.02mol, 2eq) were dissolves in 30mL
dioxane, which was in syringe C. The flow rate of syringe A, B
and C were 0.327mL/min, 0.327mL/min, and 0.654mL/min,
respectively. And the temperature of the two oil baths was set
in 70˚C and 80˚C, respectively. The reaction liquid was
collected, and dissolved in ethyl acetate, washed with H2O.
The organic layer was dried over anhydrous sodium sulfate
and solvent was removed under vacuum. And the crude
product was purified by flash chromatography on silica gel by
gradient elution with ethyl acetate in petroleum ether to
4-Morpholinyl-2-thienylmethanone (3ka).32 Light yellow oil.
1H NMR (400 MHz, CDCl3) δ 7.39 (dd, J = 5.0, 1.0 Hz, 1H), 7.22
(dd, J = 3.6, 1.0 Hz, 1H), 6.97 (dd, J = 5.0, 3.7 Hz, 1H), 3.71–3.63
(m, 8H); 13C NMR (101 MHz, CDCl3) δ 162.63, 135.57, 127.94,
127.85, 125.75, 65.82, 59.36, 20.03, 13.18.
2-Furanyl-4-morpholinylmethanone (3la).23 Yellow oil. 1H
NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 1.7, 0.8 Hz, 1H), 7.03 (dd,
J = 3.5, 0.7 Hz, 1H), 6.49 (dd, J = 3.5, 1.8 Hz, 1H), 3.82 (s, 4H),
3.77–3.72 (m, 4H); 13C NMR (101 MHz, CDCl3) δ 158.11,
146.76, 142.76, 115.81, 110.38, 65.96, 29.30.
obtain the amide product 3.
Benzoylpiperidine (3ab).23 Colourless oil. H NMR(400 MHz,
1
Benzoyl morpholine (3aa).23 White solid, H NMR(400 MHz,
CDCl3) δ 7.38–7.31 (m, 5H), 3.80–3.28 (m, 8H). HRMS (ESI) m/z
calcd for C11H13NO2 [M+H]+ 192.1019, found 192.1040.
1
CDCl3) δ 7.31(s, 5H), 3.63 (s, 2H), 3.27 (s, 2H), 1.70–1.35 (m,
6H); 13C NMR (101 MHz, CDCl3) δ 169.29, 135.51, 128.32,
127.37, 125.76, 47.75, 42.11, 25.44, 24.61, 23.57.
N-(4-Methybenzoyl)morpholine (3ba).23 Light yellow oil. H
1
Benzoylpyrrolidine (3ac).23 Colourless oil. H NMR(400 MHz,
1
NMR (400 MHz, CDCl3) δ 7.30 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.0
Hz, 2H), 3.69 (s, 8H), 2.37 (s, 3H); 13C NMR (101 MHz, CDCl3) δ
169.64, 139.08, 131.31, 128.13, 126.21, 65.90, 29.30, 20.37.
CDCl3) δ 7.51–7.26 (m, 5H), 3.56 (s, 2H), 3.36 (s, 2H), 1.84 (s,
4H); 13C NMR (101 MHz, CDCl3) δ 168.74, 136.17, 128.76,
127.22, 126.05, 48.57, 45.16, 25.36, 23.51.
(
3ad).33 Yellow oil. 1H
N-(4-Methoxybenzoyl)morpholine
(
3ca).23 Yellow oil. 1H
1-Benzoyl-4-methylpiperazine
NMR (400 MHz, CDCl3) δ 7.41–7.36 (m, 2H), 6.94–6.89 (m, 2H),
3.84 (d, J = 3.2 Hz, 3H), 3.76–3.54 (m, 8H); 13C NMR (101 MHz,
CDCl3) δ 169.43, 159.90, 128.19, 126.32, 112.78, 65.92, 54.35.
NMR(400 MHz, CDCl3) δ 7.59–7.27 (m, 5H), 3.74 (s, 2H), 3.58–
3.24 (m, 2H), 2.65–2.12(m, 7H); 13C NMR (101 MHz, CDCl3) δ
173.36, 169.33, 134.73, 128.68, 127.46, 126.01, 54.16, 53.62,
46.50, 44.89, 40.92, 20.48.
1
N-(4-Nitrobenzoyl)morpholine (3da).10 Light yellow solid. H
1-Benzoyl-4-Bocpiperazine (3ae).33 White solid. H NMR(400
1
NMR(400 MHz, CDCl3) δ 8.34–8.26 (m, 2H), 7.62–7.55 (m, 2H),
3.87–3.31 (m, 8H); 13C NMR (101 MHz, CDCl3) δ 167.04,
147.49, 140.41, 127.13, 122.96, 65.73.
MHz, CDCl3) δ 7.46–7.34 (m, 5H), 3.73 (s, 2H), 3.41 (s, 6H), 1.46
(s, 9H); 13C NMR (101 MHz, CDCl3) δ 169.60, 153.55, 134.47,
128.90, 127.58, 126.02, 79.34, 46.34, 42.85, 27.35.
N-(4-Chlorobenzoyl)morpholine (3ea).30 White solid. 1H NMR
(400 MHz, CDCl3) δ 7.38 (q, J = 8.5 Hz, 4H), 3.92–3.32 (m, 8H);
13C NMR (101 MHz, CDCl3) δ 168.37, 135.03, 132.61, 127.86,
127.65, 99.96, 65.83.
(S)-tert-Butyl-N-benzoylprolinate (3af).34 White solid. 1H
NMR (400 MHz, CDCl3) δ 7.49 (d, J = 7.5 Hz, 2H), 7.31 (dd, J =
15.5, 6.6 Hz, 5H), 4.48 (dd, J = 8.0, 5.6 Hz, 1H), 3.72 (t, J = 6.5
Hz, 1H), 3.55 (dt, J = 13.8, 7.0 Hz, 1H), 3.43 (dd, J = 13.1, 8.7 Hz,
1H), 1.99–1.87 (m, 4H), 1.43 (s, 9H), 1.33–1.13 (m, 18H); 13C
N-(4-Bromobenzoyl)morpholine (3fa).31 Light yellow solid. 1H
NMR (400 MHz, CDCl3) δ 7.58–7.54 (m, 2H), 7.31–7.27 (m, 2H),
4 | RSC Advances, 2015, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins